Italy Medical Devices Market Size, Share & Industry Analysis, By Type (Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, In-vitro Diagnostic (IVD), Minimally Invasive Surgery Devices (MIS), Wound Management, Diabetes Care Devices, Ophthalmic Devices, Dental Devices, Nephrology Devices, General Surgery, and Others), By End-user (Hospitals & ASCs, Clinics, and Others), and Country Forecast, 2025-2032

The Italy medical devices market size was valued at USD 14.19 billion in 2024. The market is projected to grow from USD 14.76 billion in 2025 to USD 20.49 billion by 2032, exhibiting a CAGR of 4.8% during the forecast period.

Medical devices refer to instruments which are used to diagnose, monitor, and treat medical conditions in patients. Some of the devices include thermometers, heart rate monitors, blood pressure monitors, wearable devices, endoscopic devices, diagnostic imaging systems, orthopedic implants, dental devices, in-vitro diagnostics, and others.

The Italy market is expected to grow significantly during the forecast period owing to increasing burden of medical complications, such as cardiovascular defects, diabetic conditions, including foot ulcers, tumors in body parts, and trauma & injuries. These complications are driving the demand for diagnostic and surgical devices, demanding a consistent supply from key players.

Medtronic, Johnson & Johnson Services, Inc., and GE Healthcare are prominent players in the Italy market. These companies are signing strategic agreements and initiating new product launches to gain a significant share of the market.

MARKET DYNAMICS

Market Drivers

Rising Geriatric Population to Spur the Demand for Medical Devices

Over the past few years, the burden of chronic medical conditions has been rising in Italy due to significant growth in the number of aged individuals, who are often more prone to chronic conditions such as diabetes, cardiovascular abnormalities, osteoporosis, and others. This is driving the demand for related medical devices in the country, as this populace often requires more frequent and intensive medical care, including diagnostic tests, monitoring devices, surgical procedures, mobility aids, and others.

• For instance, according to the data published by the Italian Institute for International Political Studies (ISPI) in January 2023, after Japan and South Korea, Italy witnessed the fastest growth in the geriatric population, with 37 individuals older than 65 years of age per 100 individuals in 2022. Moreover, the proportion of people over 80 years are projected to rise from 3.7% in 2022 to 7.5% by 2050.

Moreover, hospitals and home care settings are experiencing a significant surge in utilization of devices pacemakers, stents, implants, and remote patient monitoring systems, due to favorable reimbursements for several medical procedures in Italy. Such a scenario is anticipated to drive the Italy medical devices market growth during the forecast period.

Market Restraints

Product Recalls and Import Dependency on High-end Devices to Hinder the Market Expansion

Although there have been several new product launches with advanced technologies in Italy over the past few years, there have been defective errors detected in these devices. Also, several devices are resulting in adverse medical effects, which is lowering the confidence among healthcare providers and patients. In Italy, healthcare providers are prioritizing patient safety, which is decreasing the adoption of defective medical devices. Additionally, considering the safety guidelines, regulatory authorities are ordering the recall of such devices and suspending their usage, which is expected to hamper the product's reputation, decrease availability, and put a burden on prominent players.

Furthermore, despite the local players producing immense numbers of medical devices such as high-end imaging technologies, surgical robots, and other medical devices are largely operated by multinational companies. This is making it expensive to acquire such high-end devices in the country. This is increasing import dependency, which, as a result is hindering the adoption of new technologies, detering Italy’s medical care suppliers' ability to compete in the market. Such a scenario is anticipated to hinder the market growth during the forecast period.

Market Opportunities

Increasing Preference for Home Healthcare and Telemedicine to Offer Lucrative Growth Opportunity

In the last few years, Italy has experienced a significant demand for home healthcare devices and telemedicine kits due to the temporary closure of healthcare services from the time of COVID-19 pandemic of 2020. This led to bed shortages and decrease in the non-emergency admissions and patient visits to healthcare settings.In such a scenario, the patients with routine checkups created a significant opportunity for remote monitoring solutions and telemedicine.

Furthermore, post-pandemic, there are ongoing advancements in medical devices due to their ease of accessibility, convenience, and time-saving benefits. Also,  diabetic and cardiovascular patients are preferring products such as portable ECG monitors, blood glucose meters, blood pressure monitors, insulin administration devices, and more.  This is offering a significant opportunity for medical device companies to focus more on the development of home-based healthcare devices for monitoring, diagnosis, and therapeutics.

Also, the Italian government is emphasizing digital healthcare solutions to strengthen home care and telemedicine solutions, which is expected to provide a lucrative growth opportunity for key players, thereby expected to drive the market expansion in the coming years.

• For instance, as of January 2023, Italy’s Servizio sanitario nazionale (SSN, National Healthcare System) mentioned that they are focusing on strengthening home care and telemedicine to manage around 10.0% of individuals older than 65 years of age by 2026.

Market Challenges

Budget Constraints in Public Healthcare Systems and Shortage of Skilled Professionals to Challenge the Market Expansion

Although Italy’s public healthcare system is accessible, the healthcare expenditure allocated is still less than other countries in Europe and the U.S. For instance, according to the data published by Italy’s Servizio sanitario nazionale (SSN, National Healthcare System) in January 2023, the country’s healthcare expenditure is below the average of the other European Countries.

The country’s budget is facing a burden due to regional disparities, administrative inefficiencies, and growing healthcare costs. As a result, the medical devices sector in the country is suffering from delayed payments, decreased demand for advanced technologies such as robotic surgical systems or advanced diagnostics.

Also, the availability of limited professionals in Italy is resulting in delays for diagnostic and therapeutic procedures, as well as the implementation of advanced technologies. For instance, according to the data published by the European Observatory on Health Systems and Policies in February 2024, the shortage of healthcare professionals remains a major concern for the National Health Service (NHS) in Italy. Such a scenario is expected to challenge the market expansion in the forthcoming years.

Italy Medical Devices Market Trends

Increasing Adoption of Robotic Surgery is a Key Market Trend

Currently, robotic-assisted surgery is gaining traction in Italy due to increasing focus on the adoption of advanced technologies. Tertiary care hospitals and specialized care facilities are highly utilizing this technology to enhance surgical outcomes by reducing recovery times. The adoption is particularly higher among Tier 1 cities such as the country due to established healthcare infrastructure and higher spending capabilities. These systems are offering a minimally invasive alternative to traditional surgery, allowing surgeons to operate with higher accuracy through smaller incisions.

Additionally, this technology is benefiting patients with shortened hospital stays, reduced post-operative pain, and shortened recovery period with fewer complications. Moreover, the country’s government is focusing on increasing the adoption of innovations. This is encouraging prominent players to introduce robotic surgical systems in Italy and hospitals to involve in collaboration for the integration of robotic technologies, which is expected to reshape the surgical landscape of Italy.

• For instance, in December 2021, CMR Surgical introduced the Versius surgical robotic system at Policlinico di Milano, a research hospital and care institute (IRCCS) in Lombardy, Italy.

Download Free sample to learn more about this report.

Segmentation Analysis

By Type

In-vitro Diagnostics (IVD) Segment Dominated the Market Due to New Product Launches by Key Players

Based on type, the market is segmented into orthopedic devices, cardiovascular devices, diagnostic imaging, in-vitro diagnostic (IVD), minimally invasive surgery devices (MIS), wound management, diabetes care devices, ophthalmic devices, dental devices, nephrology devices, general surgery, and others.

The in-vitro diagnostic (IVD) dominated the market in 2024. This share is attributed to the increasing focus of key players to introduce novel in-vitro diagnostic kits in the Italy market to cater to infectious diseases, cancer, and chronic diseases in the country. These new launches are leading to competitive pricing and enhanced availability in Italy.

The orthopedic devices segment accounted for the third-largest Italy medical devices market share in 2024. The growth is attributed to the increasing incidence of trauma & injuries, and osteoarthritis in Italy, which is driving the demand for orthopedic devices such as implants. This is encouraging prominent companies to develop and launch more orthopedic devices in the country, contributing to an increased product penetration.

• For instance, according to the data published by the National Center for Biotechnology Information (NCBI) in August 2024, the prevalence of osteoarthritis was reported to be around 18.8% in 2021 in Italy.

To know how our report can help streamline your business, Speak to Analyst

By End-user

Hospitals & ASCs Dominated Due to Established Infrastructure and Higher Utilization of Advanced Technologies

Based on end-user, the market is segmented into hospitals & ASCs, clinics, and others.

The hospitals & ASCs segment held a dominating share in 2024. Italy has a well-established infrastructure, such as tertiary care hospitals, which supports the utilization of advanced medical devices such as surgical robots, AI-based diagnostics, and others. This is attracting key players to innovate and supply devices to these settings, which is expected to drive the segment’s growth.

The clinics segment held the second-largest share of the Italy market in 2024. The increasing patient preference toward specialized care and cost-effective treatment by experts is driving the number of patient visits to these settings. Such a scenario is propelling the adoption of medical tools in clinics, which is anticipated to fuel the segment’s growth in the forthcoming years.

COMPETITIVE LANDSCAPE

Key Market Players

Medtronic, Johnson & Johnson Services, Inc., and GE Healthcare Account for a Major Share due to Commercialization Efforts

The Italy market is fragmented, with major players such as Medtronic, Johnson & Johnson Services, Inc., and GE Healthcare accounting for a considerable share in 2024. The share is attributed to growing initiatives such as increasing investments, commercialization of products, and new launches in Italy, to enhance market presence.

Other major players such as Abbott, Siemens Healthineers AG, and BD. are signing strategic agreements with the country’s healthcare settings and expanding production capacities to maintain a stable supply of devices. This is expected to help these companies capture a significant portion of the Italy market during the forecast period.

LIST OF KEY ITALY MEDICAL DEVICES COMPANIES PROFILED

• Medtronic (Ireland)
• Johnson & Johnson Services, Inc. (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Boston Scientific Corporation (U.S.)
• Fresenius Medical Care AG (Germany)
• GE Healthcare (U.S.)
• Siemens Healthineers AG (Germany)
• Stryker (U.S.)
• Abbott (U.S.)
• BD (U.S.)
• FUJIFILM Corporation (Japan)

KEY INDUSTRY DEVELOPMENTS

• February 2025 – Dexcom, Inc. planned to establish a direct presence, bringing its CGM technology to Italy.
• January 2025 – Intuitive announced its plans to establish a direct presence in Italy and other countries via the acquisition of the da Vinci robot and Ion distribution businesses.
• November 2024 – Shenzhen Mindray Bio-Medical Electronics Co., Ltd. introduced the premium ultrasound system Resona A20 at EUROSON 2024 in Rome, Italy.
• June 2022 – Impulse Dynamics announced the completion of the first implants in Europe for the newly launched Optimizer Smart Mini device in Italy.
• April 2021 – TytoCare Ltd., an all-in-one modular device and examination platform for remote monitoring, entered into Italy market via a partnership with Multimed, a distribution and commercialization company for medical devices, robotics, and more.

REPORT COVERAGE

The market report provides a detailed analysis of key players, competitive landscape, and key factors driving the market growth, including trends, drivers, and opportunities. The report includes key insights such as new product launches, key industry developments, prevalence of chronic conditions, and technological advancements. It also provides company profiles of key players and segmental analysis.

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation